Patent Yard Sign in
Canadian application, no grantCanada

Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents

CA 2497159 A1 · Owner: Balzarini, Jan · Inventors: Preobrazhenskaya, Maria; Chu, Daniel T.; Balzarini, Jan

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel glycopeptide antibiotic derivatives processes for their preparation, their use as a medicine their use to treat or prevent viral infections and their use to manufacture a medicine to treat or prevent viral infections are provided. The present invention relates to the use of glycopeptide antibiotics and their semisynthetic derivatives to treat or prevent viral infections and their use to manufacture a medicine to treat or prevent viral infections of subjects, more in particular infections with viruses belonging to Retroviridae, Herpes viridae, Flaviviridae and the Coronaviridae like HIV , (human immunodeficiency virus) HCV (hepatitis C virus), BVDV (bovine viral diarrhoea …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 1, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 1, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 1, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 1, 2003
GrantedNo grant recorded
Term endedSeptember 1, 2023
Patent numberCA 2497159 A1
Classification (IPC)A61K38/14 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedSep 1, 2003Term endedSep 1, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.